Want to see IN:NECLIFE full AI Analyst Report?

Nectar Lifesciences Ltd. (NECLIFE) Financial Statements

1 Followers

Nectar Lifesciences Ltd. Financial Overview

Nectar Lifesciences Ltd.'s market cap is currently ₹2.01B. The company's EPS TTM is ₹-11.38; its P/E ratio is -0.90; and it has a dividend yield of 20.72%. Nectar Lifesciences Ltd. is scheduled to report earnings on August 14, 2026, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Jun 25	Mar 24	Mar 23	Mar 22
Income Statement
Total Revenue	₹ 20.11M	₹ 16.70B	₹ 16.84B	₹ 15.24B	₹ 16.69B
Gross Profit	₹ -590.34M	₹ 3.02B	₹ 4.82B	₹ 579.91M	₹ 2.99B
Operating Income	₹ -19.12M	₹ -888.47M	₹ 3.89B	₹ -40.98M	₹ 1.02B
EBITDA	₹ -289.51M	₹ -245.66M	₹ 1.69B	₹ 994.97M	₹ 1.61B
Net Income	₹ -2.93B	₹ -1.14B	₹ 49.95M	₹ -241.83M	₹ 250.47M
Balance Sheet
Cash & Short-Term Investments	₹ 1.25B	₹ 272.63M	₹ 203.01M	₹ 178.94M	₹ 182.35M
Total Assets	₹ 6.22B	₹ 20.47B	₹ 21.91B	₹ 21.89B	₹ 23.91B
Total Debt	₹ 0.00	₹ 5.82B	₹ 6.36B	₹ 7.54B	₹ 8.60B
Net Debt	₹ -1.12B	₹ 5.63B	₹ 6.16B	₹ 7.36B	₹ 8.42B
Total Liabilities	₹ 393.11M	₹ 10.91B	₹ 11.22B	₹ 11.25B	₹ 13.03B
Stockholders' Equity	₹ 5.82B	₹ 9.56B	₹ 10.69B	₹ 10.65B	₹ 10.88B
Cash Flow
Free Cash Flow	₹ -3.61B	₹ 1.26B	₹ 1.95B	₹ 1.04B	₹ 700.35M
Operating Cash Flow	₹ -3.49B	₹ 1.69B	₹ 2.25B	₹ 1.34B	₹ 950.05M
Investing Cash Flow	₹ 12.08B	₹ -419.30M	₹ -170.25M	₹ 517.04M	₹ 166.44M
Financing Cash Flow	₹ -7.67B	₹ -1.28B	₹ -2.05B	₹ -1.86B	₹ -1.19B

Currency in INR

Nectar Lifesciences Ltd. Earnings and Revenue History

Income Statement >

Nectar Lifesciences Ltd. Debt to Assets

Balance Sheet >

Nectar Lifesciences Ltd. Cash Flow

Cash Flow >

Nectar Lifesciences Ltd. Forecast EPS vs Actual EPS

Earnings >